Biospecimen & Biomarker Services To Advance SARS-CoV-2 Research
May 24, 2021
Biospecimen & Biomarker Services to Advance SARS-CoV-2 Research for the Development of COVID-19 Diagnostics and Targeted Therapies
SARS-CoV-2, the novel coronavirus that causes COVID-19, has exacted an enormous toll across the world, causing severe disease, death, and disruptions to society. In an effort to track, mitigate, and control the impact of the virus, unprecedented global scientific efforts have been initiated to develop new diagnostics, targeted therapies, and vaccines.
Discovery Life Sciences is on the forefront of the global scientific fight, providing biospecimens and biomarker data to help scientists understand the virus itself, such as how it spreads, infects, and evolves new variants, as well as helping researchers develop and validate new diagnostic tests, vaccines and therapies.
Connect With Us
LEVERAGING OUR COVID-19 BIOSPECIMENS & EXPERT BIOMARKER TESTING SERVICES